Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

PDL anti-HBV antibody enters phase II

Nov. 22, 1996

Novavax reports progress on products for H. pylori infection

Nov. 22, 1996

Anti-H. pylori compounds from Fujisawa

Nov. 21, 1996

Chugai describes agents that stimulate gastrointestinal motility

Nov. 21, 1996

Potential of clotrimazole in the treatment of diarrhea

Nov. 20, 1996

ProCyte copper-based compound associated with improvement in ulcerative colitis

Nov. 19, 1996

Promising clinical results for lamivudine in hepatitis

Nov. 15, 1996

Provir effective in acute diarrhea

Nov. 15, 1996

Therapeutic effect of Lilly antioxidant demonstrated in rat model of IBD

Nov. 15, 1996

Roberts to license Lilly gastrointestinal compounds

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.